1
Unlocking unique clinical research roadmaps using a systems approach When: Monday 15 September 2014, 12:45pm - 2:00pm Where: Room 218, The Melbourne Convention Centre Cost: Free “From Bench to Bedside” neatly captures the goal of translating basic medical research to clinical outcomes. However, the simplicity of this expression belies a world of complexity, from the initial discovery of clinical targets, to effective translation to therapies, and the numerous regulatory hurdles. But there are new roadmaps being forged using emerging systems biology platforms that offer researchers unique and sensitive navigation tools that can fast track the journey. Our panel of experts will present stateofart initiatives that showcase the future of this approach. Join us to hear their insights, and participate in a Q&A forum with the panel. Jonathan Fitzgerald, Ph.D. Vice President, Discovery, Merrimack Pharmaceuticals “Using Systems Biology Approaches to Guide Drug & Diagnostic Development” Maureen Turner Chief Executive Officer, BioGrid Australia Ltd., Australia “Realtime integration of federated genomic and clinical data making personalised medicine possible” Hiroaki Kitano, Ph.D. President, The Systems Biology Institute, and Principal Investigator, Laboratory for Disease Systems Modeling, RIKEN Center for Integrative Medical Sciences TBC This free event is part of the International Conference for Systems Biology: www.icsb14.com This Systems Biology Collaborative is part of the Enhancing Systems Biology In Victoria program, run by SBI Australia with support from the Victorian State Government.

Flyer for Drug Design Collaborative 15 Sep 14

  • Upload
    hn

  • View
    212

  • Download
    0

Embed Size (px)

DESCRIPTION

Flyer for Drug Design Collaborative

Citation preview

Page 1: Flyer for Drug Design Collaborative 15 Sep 14

Unlocking unique clinical research roadmaps using a systems approach

When: Monday 15 September 2014, 12:45pm - 2:00pm

Where: Room 218, The Melbourne Convention Centre

Cost: Free

“From  Bench  to  Bedside”  neatly  captures  the  goal  of  translating  basic  medical  research  to  clinical  outcomes.    However,  the  simplicity  of  this  expression  belies  a  world  of  complexity,  from  the  initial  discovery  of  clinical  targets,  to  effective  translation  to  therapies,  and  the  numerous  regulatory  hurdles.    But  there  are  new  roadmaps  being  forged  using  emerging  systems  biology  platforms  that  offer  researchers  unique  and  sensitive  navigation  tools  that  can  fast  track  the  journey.  

Our  panel  of  experts  will  present  state-­‐of-­‐art  initiatives  that  showcase  the  future  of  this  approach.    Join  us  to  hear  their  insights,  and  participate  in  a  Q&A  forum  with  the  panel.  

Jonathan  Fitzgerald,  Ph.D.  Vice  President,  Discovery,  Merrimack  Pharmaceuticals    “Using  Systems  Biology  Approaches  to  Guide  Drug  &  Diagnostic  Development”        Maureen  Turner  Chief  Executive  Officer,  BioGrid  Australia  Ltd.,  Australia    “Real-­‐time  integration  of  federated  genomic  and  clinical  data  making  personalised  medicine  possible”      Hiroaki  Kitano,  Ph.D.  President,  The  Systems  Biology  Institute,  and  Principal  Investigator,  Laboratory  for  Disease  Systems  Modeling,  RIKEN  Center  for  Integrative  Medical  Sciences    TBC  

This free event is part of the International Conference for Systems Biology: www.icsb14.com

This Systems Biology Collaborative is part of the Enhancing Systems Biology In Victoria program, run by SBI Australia with support from the Victorian State Government.